NCT06346600 - A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

March 31, 2031

Study Completion Date

March 31, 2031

Conditions

Neovascular (Wet) Age-related Macular Degeneration

Interventions

GENETIC

SKG0106

Non-interventional (observational) study, long-term follow-up safety and efficacy assessments up to 5 years post SKG0106 injection.

Trial Locations (10)

NOT_YET_RECRUITING

Wagner Macula & Retina Center, Norfolk

NOT_YET_RECRUITING

Retina Consultants of Texas, Katy

NOT_YET_RECRUITING

Ophthalmic Consultants of Boston, Boston

NOT_YET_RECRUITING

The Second Hospital Of Anhui Medical University, Hefei

NOT_YET_RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

NOT_YET_RECRUITING

Eye Hospital, WMU (Zhejiang Eye Hospital), Wenzhou

NOT_YET_RECRUITING

Beijing Hospital, Beijing

RECRUITING

Peking Union Medical College Hospital, Beijing

RECRUITING

EYE & ENT Hospital of Fudan University, Shanghai

NOT_YET_RECRUITING

Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine, Shanghai